学术探索
学术期刊
新闻热点
数据分析
智能评审
立即登录
DELTA-9-TETRAHYDROCANNABINOL FOR REFRACTORY VOMITING INDUCED BY CANCER-CHEMOTHERAPY
被引:103
作者
:
LUCAS, VS
论文数:
0
引用数:
0
h-index:
0
机构:
DUKE UNIV,MED CTR,DEPT MED,DURHAM,NC 27710
DUKE UNIV,MED CTR,DEPT MED,DURHAM,NC 27710
LUCAS, VS
[
1
]
LASZLO, J
论文数:
0
引用数:
0
h-index:
0
机构:
DUKE UNIV,MED CTR,DEPT MED,DURHAM,NC 27710
DUKE UNIV,MED CTR,DEPT MED,DURHAM,NC 27710
LASZLO, J
[
1
]
机构
:
[1]
DUKE UNIV,MED CTR,DEPT MED,DURHAM,NC 27710
来源
:
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
|
1980年
/ 243卷
/ 12期
关键词
:
D O I
:
10.1001/jama.243.12.1241
中图分类号
:
R5 [内科学];
学科分类号
:
1002 ;
100201 ;
摘要
:
引用
收藏
页码:1241 / 1243
页数:3
相关论文
共 8 条
[1]
FURNAS BE, 1978, 20TH AM CANC SOC SCI
[2]
GOODMAN LS, 1975, PHARMACOL BASIS, P157
[3]
SUPERIORITY OF NABILONE OVER PROCHLORPERAZINE AS AN ANTI-EMETIC IN PATIENTS RECEIVING CANCER-CHEMOTHERAPY
HERMAN, TS
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV ARIZONA,COLL MED,CTR CANC,TUCSON,AZ 85724
HERMAN, TS
EINHORN, LH
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV ARIZONA,COLL MED,CTR CANC,TUCSON,AZ 85724
EINHORN, LH
JONES, SE
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV ARIZONA,COLL MED,CTR CANC,TUCSON,AZ 85724
JONES, SE
NAGY, C
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV ARIZONA,COLL MED,CTR CANC,TUCSON,AZ 85724
NAGY, C
CHESTER, AB
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV ARIZONA,COLL MED,CTR CANC,TUCSON,AZ 85724
CHESTER, AB
DEAN, JC
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV ARIZONA,COLL MED,CTR CANC,TUCSON,AZ 85724
DEAN, JC
FURNAS, B
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV ARIZONA,COLL MED,CTR CANC,TUCSON,AZ 85724
FURNAS, B
WILLIAMS, SD
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV ARIZONA,COLL MED,CTR CANC,TUCSON,AZ 85724
WILLIAMS, SD
LEIGH, SA
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV ARIZONA,COLL MED,CTR CANC,TUCSON,AZ 85724
LEIGH, SA
DORR, RT
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV ARIZONA,COLL MED,CTR CANC,TUCSON,AZ 85724
DORR, RT
MOON, TE
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV ARIZONA,COLL MED,CTR CANC,TUCSON,AZ 85724
MOON, TE
[J].
NEW ENGLAND JOURNAL OF MEDICINE,
1979,
300
(23)
: 1295
-
1297
[4]
PEREZREY.M, 1973, CLIN PHARMACOL THER, V14, P48
[5]
REGELSON W, 1976, PHARMACOLOGY MARIHUA
[6]
CIS-DIAMMINEDICHLOROPLATINUM(II) - NEW ANTICANCER DRUG
ROZENCWEIG, M
论文数:
0
引用数:
0
h-index:
0
机构:
NCI, CANC THERAPY EVALUAT PROGRAM, BETHESDA, MD 20014 USA
NCI, CANC THERAPY EVALUAT PROGRAM, BETHESDA, MD 20014 USA
ROZENCWEIG, M
VONHOFF, DD
论文数:
0
引用数:
0
h-index:
0
机构:
NCI, CANC THERAPY EVALUAT PROGRAM, BETHESDA, MD 20014 USA
NCI, CANC THERAPY EVALUAT PROGRAM, BETHESDA, MD 20014 USA
VONHOFF, DD
SLAVIK, M
论文数:
0
引用数:
0
h-index:
0
机构:
NCI, CANC THERAPY EVALUAT PROGRAM, BETHESDA, MD 20014 USA
NCI, CANC THERAPY EVALUAT PROGRAM, BETHESDA, MD 20014 USA
SLAVIK, M
MUGGIA, FM
论文数:
0
引用数:
0
h-index:
0
机构:
NCI, CANC THERAPY EVALUAT PROGRAM, BETHESDA, MD 20014 USA
NCI, CANC THERAPY EVALUAT PROGRAM, BETHESDA, MD 20014 USA
MUGGIA, FM
[J].
ANNALS OF INTERNAL MEDICINE,
1977,
86
(06)
: 803
-
812
[7]
ANTIEMETIC EFFECT OF DELTA-9-TETRAHYDROCANNABINOL IN PATIENTS RECEIVING CANCER CHEMOTHERAPY
SALLAN, SE
论文数:
0
引用数:
0
h-index:
0
机构:
PETER BENT BRIGHAM HOSP,SIDNEY FARBER CANC CTR,BOSTON,MA
SALLAN, SE
ZINBERG, NE
论文数:
0
引用数:
0
h-index:
0
机构:
PETER BENT BRIGHAM HOSP,SIDNEY FARBER CANC CTR,BOSTON,MA
ZINBERG, NE
FREI, E
论文数:
0
引用数:
0
h-index:
0
机构:
PETER BENT BRIGHAM HOSP,SIDNEY FARBER CANC CTR,BOSTON,MA
FREI, E
[J].
NEW ENGLAND JOURNAL OF MEDICINE,
1975,
293
(16)
: 795
-
797
[8]
WHITEHEAD VM, 1975, NEW ENGL J MED, V293, P199
←
1
→
共 8 条
[1]
FURNAS BE, 1978, 20TH AM CANC SOC SCI
[2]
GOODMAN LS, 1975, PHARMACOL BASIS, P157
[3]
SUPERIORITY OF NABILONE OVER PROCHLORPERAZINE AS AN ANTI-EMETIC IN PATIENTS RECEIVING CANCER-CHEMOTHERAPY
HERMAN, TS
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV ARIZONA,COLL MED,CTR CANC,TUCSON,AZ 85724
HERMAN, TS
EINHORN, LH
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV ARIZONA,COLL MED,CTR CANC,TUCSON,AZ 85724
EINHORN, LH
JONES, SE
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV ARIZONA,COLL MED,CTR CANC,TUCSON,AZ 85724
JONES, SE
NAGY, C
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV ARIZONA,COLL MED,CTR CANC,TUCSON,AZ 85724
NAGY, C
CHESTER, AB
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV ARIZONA,COLL MED,CTR CANC,TUCSON,AZ 85724
CHESTER, AB
DEAN, JC
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV ARIZONA,COLL MED,CTR CANC,TUCSON,AZ 85724
DEAN, JC
FURNAS, B
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV ARIZONA,COLL MED,CTR CANC,TUCSON,AZ 85724
FURNAS, B
WILLIAMS, SD
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV ARIZONA,COLL MED,CTR CANC,TUCSON,AZ 85724
WILLIAMS, SD
LEIGH, SA
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV ARIZONA,COLL MED,CTR CANC,TUCSON,AZ 85724
LEIGH, SA
DORR, RT
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV ARIZONA,COLL MED,CTR CANC,TUCSON,AZ 85724
DORR, RT
MOON, TE
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV ARIZONA,COLL MED,CTR CANC,TUCSON,AZ 85724
MOON, TE
[J].
NEW ENGLAND JOURNAL OF MEDICINE,
1979,
300
(23)
: 1295
-
1297
[4]
PEREZREY.M, 1973, CLIN PHARMACOL THER, V14, P48
[5]
REGELSON W, 1976, PHARMACOLOGY MARIHUA
[6]
CIS-DIAMMINEDICHLOROPLATINUM(II) - NEW ANTICANCER DRUG
ROZENCWEIG, M
论文数:
0
引用数:
0
h-index:
0
机构:
NCI, CANC THERAPY EVALUAT PROGRAM, BETHESDA, MD 20014 USA
NCI, CANC THERAPY EVALUAT PROGRAM, BETHESDA, MD 20014 USA
ROZENCWEIG, M
VONHOFF, DD
论文数:
0
引用数:
0
h-index:
0
机构:
NCI, CANC THERAPY EVALUAT PROGRAM, BETHESDA, MD 20014 USA
NCI, CANC THERAPY EVALUAT PROGRAM, BETHESDA, MD 20014 USA
VONHOFF, DD
SLAVIK, M
论文数:
0
引用数:
0
h-index:
0
机构:
NCI, CANC THERAPY EVALUAT PROGRAM, BETHESDA, MD 20014 USA
NCI, CANC THERAPY EVALUAT PROGRAM, BETHESDA, MD 20014 USA
SLAVIK, M
MUGGIA, FM
论文数:
0
引用数:
0
h-index:
0
机构:
NCI, CANC THERAPY EVALUAT PROGRAM, BETHESDA, MD 20014 USA
NCI, CANC THERAPY EVALUAT PROGRAM, BETHESDA, MD 20014 USA
MUGGIA, FM
[J].
ANNALS OF INTERNAL MEDICINE,
1977,
86
(06)
: 803
-
812
[7]
ANTIEMETIC EFFECT OF DELTA-9-TETRAHYDROCANNABINOL IN PATIENTS RECEIVING CANCER CHEMOTHERAPY
SALLAN, SE
论文数:
0
引用数:
0
h-index:
0
机构:
PETER BENT BRIGHAM HOSP,SIDNEY FARBER CANC CTR,BOSTON,MA
SALLAN, SE
ZINBERG, NE
论文数:
0
引用数:
0
h-index:
0
机构:
PETER BENT BRIGHAM HOSP,SIDNEY FARBER CANC CTR,BOSTON,MA
ZINBERG, NE
FREI, E
论文数:
0
引用数:
0
h-index:
0
机构:
PETER BENT BRIGHAM HOSP,SIDNEY FARBER CANC CTR,BOSTON,MA
FREI, E
[J].
NEW ENGLAND JOURNAL OF MEDICINE,
1975,
293
(16)
: 795
-
797
[8]
WHITEHEAD VM, 1975, NEW ENGL J MED, V293, P199
←
1
→